InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+30.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Sukhtian Faisal Ghiath, Director. Officer active across 1 company, notably Outlook Therapeutics, Inc.. In total, 4 disclosures have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €150k. Activity tracked since 2 December 2021. The latest transaction was disclosed on 29 July 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Sukhtian Faisal Ghiath
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
95,398 shares@ US$1.04820.060% mcap58.7% of flowCommon StockSEC:0001649989-26-000008:0
Canonical exit: 27 Oct 2026 (T+90)
30,000 shares@ US$1.2947.0% of flowCommon StockSEC:0001209191-22-053357:0
Canonical exit: 5 Jan 2023 (T+90)
27,982,529 sharesCommon StockSEC:0000947871-22-000476:0
18,000 shares@ US$1.4036.0% of flowCommon StockSEC:0001209191-21-067648:0
Canonical exit: 2 Mar 2022 (T+90)
4 of 4 declarations
About Sukhtian Faisal Ghiath
Faisal Ghiath Sukhtian is a Board Member at Outlook Therapeutics, Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and overseeing operations. His expertise is valuable in guiding the company's initiatives.
